Skip to main content
The Egyptian Journal of Bronchology
Download PDF
  • Original article
  • Open access
  • Published:

Assessment of coronary artery diseases in COPD

Egyptian Journal of Bronchology volume 12, pages 391–398 (2018)Cite this article

Abstract

Context

Chronic obstructive pulmonary disease (COPD) is associated with significant systemic inflammatory response, with downstream adverse clinical effects. This inflammatory response is referred to oxidative stress and inflammatory mediators, which play an important role in the development of atherosclerosis. Preclinical carotid atherosclerosis, characterized by increased intima-media thickness (IMT) on ultrasound imaging, is a surrogate marker for atherosclerosis burden and risk of cardiovascular diseases.

Aim

To evaluate carotid IMT, in relation to post-forced expiratory volume in 1 s (FEV1) (FEV1 after bronchodilator inhalation) in COPD.

Patients and methods

A total of 50 patients with COPD were clinically and functionally diagnosed. IMT was measured by B-mode ultrasonography. The correlations between IMT, C-reactive protein (CRP), serum lipids, and post-FEV1 were analyzed. The primary outcome was carotid arteries’ IMT in relation to post-FEV1.

Results

Cases were divided into three groups according to post-FEV1. In mild COPD severity, mean±SD IMT value was 1.0±0.2, whereas in moderate severity, it was 1.5±0.2, and in severe COPD, IMT was 1.75±0.05 (P<0.001). In mild group, mean±SD value of CRP was 5.2±1.7, in moderate group was 7.5±1.5, and in severe COPD group was 8.4±0.2 (P<0.001). When CRP was correlated with IMT, the correlation was found to be highly significant (P<0.001). In severe airway obstruction group, mean values of serum cholesterol and triglycerides were 239.5 and 189.5, respectively; in moderate group 219.4 and 161.9, respectively; and in mild group 184.2 and 125.6, respectively (P<0.000). Multinomial logistic regression analysis revealed low post-FEV1 as predictor of IMT (P<0.000).

Conclusion

Carotid duplex should be added to the standard investigations of COPD.

References

  1. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest J 2007;131:1557–66.

    Article  CAS  Google Scholar 

  2. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009;33:1165–85.

    Article  CAS  Google Scholar 

  3. Mendall MA, Strachan DP, Butland BK, Ballam L, Morris J, Sweetnam PM, Elwood PC. C-reactive protein:relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J 2000;21:1584–90.

    Article  CAS  Google Scholar 

  4. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease:prospective study and updated meta-analyses. BMJ 2000;321:199–204.

    Article  CAS  Google Scholar 

  5. Truelsen T, Postscott E, Lange P, Schnohr P, Boysen G. Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. Int J Epidemiol 2001;30:145–51.

    Article  CAS  Google Scholar 

  6. Doehner W, Haeusler KG, Endres M, Anker SD, MacNee W, Lainscak M. Neurological and endocrinological disorders:orphans in chronic obstructive pulmonary disease. Respir Med 2011;105:S12–9.

    Article  Google Scholar 

  7. Zureik M, Kauffmann F, Touboul PJ, Courbon D, Ducimetière P. Association between peak expiratory flow and the development of carotid atherosclerotic plaques. Arch Intern Med 2001;161:1669–76.

    Article  CAS  Google Scholar 

  8. Howard G, Sharrett AR, Heiss G, Evans GW, Chambless LE, Riley WA, Burke GL. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 1993;24:1297–304.

    Article  CAS  Google Scholar 

  9. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and postvention of chronic obstructive pulmonary disease. Seattle, WA:Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2015.

    Google Scholar 

  10. Eigenbrodt ML, Bursac Z, Tracy RE, Mehta JL, Rose KM, Couper DJ. B-mode ultrasound common carotid artery intima-media thickness and external diameter:cross-sectional and longitudinal associations with carotid atherosclerosis in a large population sample. Cardiovasc Ultrasound 2008; 6:10.

    Article  Google Scholar 

  11. Hamrah MS, Suzuki S, Ishii H, Shibata Y, Tatami Y, Osugi N, et al. Impact of airflow limitation on carotid atherosclerosis in coronary artery disease patients. Respiration 2015;89:322–8.

    Article  Google Scholar 

  12. Chindhi S, Thakur S, Sarkar M, Negi PC. Subclinical atherosclerotic vascular disease in chronic obstructive pulmonary disease:prospective hospital-based case control study. Lung India 2015;32:137–141.

    Article  Google Scholar 

  13. Sadek SH, Hassan AA, AbdElrahman G, Kasem SM, AbdElwahed L, Eldein HS, Zedan M. Subclinical cardiovascular changes in chronic obstructive pulmonary disease patients:Doppler ultrasound evaluation. Egypt J Bronchol 2015; 9:140.

    Article  Google Scholar 

  14. Pan J, Xu L, Cai SX, Jiang CQ, Cheng KK, Zhao HJ, et al. The association of pulmonary function with carotid atherosclerosis in older Chinese:Guangzhou Biobank Cohort Study-CVD Subcohort. Atherosclerosis 2015;243:469–476.

    Article  CAS  Google Scholar 

  15. van Gestel YR, Flu WJ, van Kuijk JP, Hoeks SE, Bax JJ, Sin DD, Poldermans D. Association of COPD with carotid wall intima-media thickness in vascular surgery patients. Respir Med 2010;104:712–716.

    Article  Google Scholar 

  16. Kim SJ, Yoon DW, Lee EJ, Hur GY, Jung KH, Lee SY, et al. Carotid atherosclerosis in patients with untreated chronic obstructive pulmonary disease. Int J Tuberculos Lung Dis 2011; 15 (9):1265–1270.

    Article  CAS  Google Scholar 

  17. Alpaydin AO, Arslan IK, Serter S, Coskun AS, Celik P, Taneli F, Yorgancioglu A. Metabolic syndrome and carotid intima-media thickness in chronic obstructive pulmonary disease. Multidiscip Respir Med 2013; 8:61.

    Article  Google Scholar 

  18. Zhang X, Li D, Wang H, Pang C, Wu Y, Wen F. Gender difference in plasma fatty-acid-binding protein 4 levels in patients with chronic obstructive pulmonary disease. Biosci Rep 2016; 36:e00303.

    Article  Google Scholar 

  19. Gudmundsson G, Margretardottir OB, Sigurdsson MI, Harris TB, Launer LJ, SigurdssonS, etal. Airflowobstruction,atherosclerosis andcardiovascular risk factors in the AGES Reykjavik study. Atherosclerosis 2016;252:122–127.

    Article  CAS  Google Scholar 

  20. Cibicková L,Karásek D,LangováK,Vaverková H,OrságJ, Lukes J,Novotný D. Correlation of lipid parameters and markers of insulin resistance:does smoking make a difference?. Physiolog Res 2014; 63:S387.

    Google Scholar 

  21. Rao MV, Raghu S, Rao CH. A study of lipid profile in chronic obstructive pulmonary disease. J Evol Med Dent Sci. 2015;4:7287–7297.

    Article  CAS  Google Scholar 

  22. Fatima F, Fatima S, Noor MM, Abbasi MA, Jadoon RJ, Sohail M, et al. Comparison of peak expiratory flow rate and lipid profile in asymptomatic smokers and non-smokers. J Ayub Med Coll Abbottab 2015;27:55–60.

    Google Scholar 

  23. Ulubafl B, Çimen F, Erylmaz T, Budayc R, Çalkolu M. Lipid profile in patients with chronic obstructive pulmonary disease. Respir J 2003;4:120–122.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Medicine, Helwan University, 11931, Helwan, Maadi, Cairo, Egypt

    Fatmaalzahraa S. Abdalrazik MD & Waleed M. El-Sorougi

Authors
  1. Fatmaalzahraa S. Abdalrazik MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Waleed M. El-Sorougi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fatmaalzahraa S. Abdalrazik MD.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abdalrazik, F.S., El-Sorougi, W.M. Assessment of coronary artery diseases in COPD. Egypt J Bronchol 12, 391–398 (2018). https://doi.org/10.4103/ejb.ejb_39_18

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejb.ejb_39_18

Keywords